title: The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females.
abstract: BACKGROUND
  Polycystic ovary syndrome (PCOS) is associated with metabolic abnormalities which are also parts of metabolic syndrome (MetS). It is debated whether all women with PCOS should be screened for MetS and Insulin resistance (IR), since they may vary in terms of PCOS phenotype, ethnicity and age. This large scale study aimed to determine the prevalence of MetS among Iranian women diagnosed with different phenotypic subgroups of PCOS based on the Rotterdam criteria.
  
  
  METHODS
  This study was conducted from January 2006 to June 2008 in Isfahan, Iran. The study population comprised females diagnosed with PCOS referred to the infertility clinic. The subjects were divided into for subgroups according to different phenotypes of PCOS based on the Rotterdam criteria. They underwent metabolic screening according to NCEP ATP III guidelines and IR screening based on homeostasis model assessment (HOMA) of insulin resistance.
  
  
  RESULTS
  The prevalence of MetS and IR were 24.9% and 24.3%, respectively. A significant difference in the prevalence of MetS was documented between anovulatory women having PCOS with or without hyperandrogenism (23.1% and 13.9%, respectively; P = 0.001). Likewise, in PCOS women with hyperandrogenism, the MetS prevalence differed among those with or without polycystic ovary (23.1% and 63.8%, respectively; P = 0.001).
  
  
  CONCLUSIONS
  The prevalence of MetS and IR varies between the phenotypic subgroups of PCOS. Hyperandrogenemia PCOS phenotypes of Iranian women, in particular those without sonographic polycystic ovary, are highly at risk of MetS and IR.
authors.affiliation: Associate Professor, Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
authors.forename: Ferdous
authors.initials: F
authors.lastname: Mehrabian
authors.forename: Behnaz
authors.initials: B
authors.lastname: Khani
authors.forename: Roya
authors.initials: R
authors.lastname: Kelishadi
authors.forename: Narges
authors.initials: N
authors.lastname: Kermani
references.citation: Circulation. 2002 Dec 17;106(25):3143-421
references.pmid: 12485966
references.citation: Br J Nutr. 2000 Mar;83 Suppl 1:S5-8
references.pmid: 10889785
references.citation: Hum Reprod. 2003 Nov;18(11):2289-93
references.pmid: 14585875
references.citation: Ann Intern Med. 2000 Jun 20;132(12):989-93
references.pmid: 10858183
references.citation: Diabetes. 2004 Sep;53(9):2353-8
references.pmid: 15331545
references.citation: Obstet Gynecol Surv. 2004 Feb;59(2):141-54
references.pmid: 14752302
references.citation: Diabetes Care. 2003 Oct;26(10):2796-803
references.pmid: 14514582
references.citation: J Clin Endocrinol Metab. 1992 Aug;75(2):577-83
references.pmid: 1322430
references.citation: Endocrinology. 1988 Aug;123(2):733-9
references.pmid: 2969325
references.citation: Diabetes. 1992 Oct;41(10):1257-66
references.pmid: 1397698
references.citation: Fertil Steril. 2008 Oct;90(4):1139-43
references.pmid: 17889857
references.citation: J Clin Endocrinol Metab. 1983 Aug;57(2):356-9
references.pmid: 6223044
references.citation: Endocr Rev. 1997 Dec;18(6):774-800
references.pmid: 9408743
references.citation: Hum Reprod. 2000 Jun;15(6):1266-74
references.pmid: 10831553
references.citation: Diabetes Care. 2009 Jun;32(6):1092-7
references.pmid: 19279302
references.citation: Obstet Gynecol. 2005 Jul;106(1):131-7
references.pmid: 15994628
references.citation: N Engl J Med. 1996 Aug 29;335(9):617-23
references.pmid: 8687515
references.citation: Endokrynol Pol. 2011;62(3):238-42
references.pmid: 21717406
references.citation: Fertil Steril. 2004 Jan;81(1):19-25
references.pmid: 14711538
references.citation: Exp Clin Endocrinol Diabetes. 2006 Apr;114(4):175-81
references.pmid: 16705549
references.citation: Fertil Steril. 2005 Aug;84(2):413-9
references.pmid: 16084883
references.citation: Metabolism. 2003 Jul;52(7):908-15
references.pmid: 12870169
references.citation: Am J Obstet Gynecol. 2008 Jun;198(6):670.e1-7; discussion 670.e7-10
references.pmid: 18355776
references.citation: Eur J Endocrinol. 2006 Jan;154(1):141-5
references.pmid: 16382003
references.citation: Am J Obstet Gynecol. 2002 Nov;187(5):1362-9
references.pmid: 12439532
references.citation: J Clin Endocrinol Metab. 2005 Apr;90(4):1929-35
references.pmid: 15623819
references.citation: Arch Intern Med. 2003 Feb 24;163(4):427-36
references.pmid: 12588201
references.citation: Int J Gynaecol Obstet. 2001 Sep;74(3):261-7
references.pmid: 11543750
references.citation: Clin Endocrinol (Oxf). 2000 May;52(5):595-600
references.pmid: 10792339